InspireMD (NSPR) Revenue Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 81.93% |
| Sep 30, 2025 | 20.82% |
| Jun 30, 2025 | 41.54% |
| Mar 31, 2025 | 8.14% |
| Dec 31, 2024 | 13.98% |
| Sep 30, 2024 | 14.03% |
| Jun 30, 2024 | 5.13% |
| Mar 31, 2024 | 29.49% |
| Dec 31, 2023 | 16.46% |
| Sep 30, 2023 | 15.14% |
| Jun 30, 2023 | 10.45% |
| Mar 31, 2023 | 4.23% |
| Dec 31, 2022 | 4.23% |
| Sep 30, 2022 | 14.79% |
| Jun 30, 2022 | 19.06% |
| Mar 31, 2022 | 15.76% |
| Dec 31, 2021 | 33.78% |
| Sep 30, 2021 | 17.96% |
| Jun 30, 2021 | 13.96% |
| Mar 31, 2021 | 12.31% |
| Dec 31, 2020 | -21.08% |
| Sep 30, 2020 | 9.17% |
| Jun 30, 2020 | -14.50% |
| Mar 31, 2019 | -22.48% |
| Sep 30, 2018 | -13.10% |
| Jun 30, 2018 | -7.73% |
| Mar 31, 2018 | -7.83% |
| Dec 31, 2017 | -9.18% |
| Sep 30, 2017 | 7.12% |
| Mar 31, 2017 | -12.94% |
| Dec 31, 2016 | -24.26% |
| Sep 30, 2016 | -25.07% |
| Jun 30, 2016 | -12.29% |
| Mar 31, 2016 | -19.70% |
| Dec 31, 2015 | -6.47% |
| Sep 30, 2015 | -12.37% |
| Jun 30, 2015 | -5.48% |